Apollo Hospitals MD On Drug Price Caps: How Much Will Margins Be Hit?
NDTV Profit · 05 Nov 2026 · 9 min
Management interview of Apollo Hospitals Enterprise Ltd (APOLLOHOSP), with 9 key numbers discussed.
- Suneeta Reddy, Managing Director, Apollo Hospitals
Apollo Hospitals confirmed it is on track to deliver close to 20% revenue growth in FY27, backed by strong volume expansion. Hospital business saw 14% volume growth in Q2FY27, alongside a 37% jump in international patients. Management stated that proposed drug price caps would have only a slight impact, as volume growth and value-chain integration will absorb the hit. Apollo 24/7 is already cash profitable, and mature pharmacy stores are operating at 10% margins.